Instil Bio, Inc. (TIL)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Sep 04, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Price : 7.58 for Sept. 4, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 04, 2026 | 7.59 | 7.64 | 7.58 | 7.58 | 3011.00 |
| Sep 03, 2026 | 7.71 | 7.78 | 7.584 | 7.66 | 6456.00 |
| Sep 02, 2026 | 7.73 | 7.79 | 7.67 | 7.685 | 3883.00 |
| Sep 01, 2026 | 7.71 | 7.81 | 7.59 | 7.69 | 11900.00 |
| Aug 31, 2026 | 7.56 | 7.69 | 7.54 | 7.61 | 2601.00 |
| Aug 28, 2026 | 7.79 | 7.83 | 7.450 | 7.58 | 14491.00 |
| Aug 27, 2026 | 7.685 | 7.875 | 7.600 | 7.86 | 8285.00 |
| Aug 26, 2026 | 7.745 | 7.89 | 7.62 | 7.83 | 10692.00 |
| Aug 25, 2026 | 7.75 | 7.88 | 7.60 | 7.60 | 5378.00 |
| Aug 24, 2026 | 7.72 | 7.81 | 7.60 | 7.81 | 12789.00 |
| Aug 21, 2026 | 7.40 | 7.88 | 7.40 | 7.58 | 9205.00 |
| Aug 20, 2026 | 7.32 | 7.483 | 7.32 | 7.43 | 3174.00 |
| Aug 19, 2026 | 7.41 | 7.44 | 7.39 | 7.39 | 2828.00 |
| Aug 18, 2026 | 7.37 | 7.40 | 7.300 | 7.31 | 2663.00 |
| Aug 17, 2026 | 7.40 | 7.48 | 7.325 | 7.36 | 5544.00 |
| Aug 14, 2026 | 7.30 | 7.500 | 7.30 | 7.38 | 13524.00 |
| Aug 13, 2026 | 7.32 | 7.50 | 7.260 | 7.27 | 11885.00 |
| Aug 12, 2026 | 7.270 | 7.48 | 7.270 | 7.48 | 3805.00 |
| Aug 11, 2026 | 7.47 | 7.500 | 7.37 | 7.49 | 6982.00 |
| Aug 10, 2026 | 7.27 | 7.41 | 7.260 | 7.41 | 1009.00 |
| Aug 07, 2026 | 7.345 | 7.49 | 7.270 | 7.41 | 11774.00 |
| Aug 06, 2026 | 7.34 | 7.49 | 7.21 | 7.28 | 2281.00 |
| Aug 05, 2026 | 7.175 | 7.30 | 7.140 | 7.26 | 9583.00 |
| Aug 04, 2026 | 7.13 | 7.50 | 7.022 | 7.25 | 12541.00 |
| Aug 03, 2026 | 7.12 | 7.28 | 7.12 | 7.22 | 10340.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 28.02 |
| Alnylam Pharmaceuticals, Inc. | 266.11 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.19 |
Price Related Metrics
| Price to Book Value | 0.4787 |
| Earnings Yield | -59.00% |
| Market Cap | 51.41M |